Cargando…

Impact of regular physical activity on weekly warfarin dose requirement

Warfarin is an oral anticoagulant agent with a narrow therapeutic index. There is a marked inter- and intra-patient variability in warfarin dose requirement. All factors influencing warfarin response are not known and this study aims to evaluate if regular physical activity (RPA) is a determining fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouleau-Mailloux, Étienne, Shahabi, Payman, Dumas, Stéphanie, Feroz Zada, Yassamin, Provost, Sylvie, Hu, Jason, Nguyen, Jacqueline, Bouchama, Nawal, Mongrain, Ian, Talajic, Mario, Tardif, Jean-Claude, Perreault, Sylvie, Dubé, Marie-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735233/
https://www.ncbi.nlm.nih.gov/pubmed/26238769
http://dx.doi.org/10.1007/s11239-015-1248-9
_version_ 1782413043493240832
author Rouleau-Mailloux, Étienne
Shahabi, Payman
Dumas, Stéphanie
Feroz Zada, Yassamin
Provost, Sylvie
Hu, Jason
Nguyen, Jacqueline
Bouchama, Nawal
Mongrain, Ian
Talajic, Mario
Tardif, Jean-Claude
Perreault, Sylvie
Dubé, Marie-Pierre
author_facet Rouleau-Mailloux, Étienne
Shahabi, Payman
Dumas, Stéphanie
Feroz Zada, Yassamin
Provost, Sylvie
Hu, Jason
Nguyen, Jacqueline
Bouchama, Nawal
Mongrain, Ian
Talajic, Mario
Tardif, Jean-Claude
Perreault, Sylvie
Dubé, Marie-Pierre
author_sort Rouleau-Mailloux, Étienne
collection PubMed
description Warfarin is an oral anticoagulant agent with a narrow therapeutic index. There is a marked inter- and intra-patient variability in warfarin dose requirement. All factors influencing warfarin response are not known and this study aims to evaluate if regular physical activity (RPA) is a determining factor. RPA level was collected with the Stanford Brief Activity Survey in 1064 incident warfarin users, as part of the Quebec Warfarin Cohort (QWC), and with the Global Physical Activity Questionnaire in 618 patients from the Montreal Heart Institute (MHI) Biobank. Linear regression was performed to model relationship of warfarin dose after 3 months of therapy in the QWC with RPA, while controlling for height, weight, age, CYP2C9 (*2 and *3 alleles) and VKORC1 (*2 allele) genotype. Warfarin dose of prevalent users was modeled in the MHI Biobank for replication. A higher level of physical activity was associated with higher doses of warfarin in both cohorts. In the QWC, physical activity could explain 5.4 % (P < 0.001) and 0.9 % (P = 3.23 × 10(−5)) of variance in dose, in univariate and multivariable models, respectively. Similarly, RPA was found to be associated with 1.7 % (P = 0.0012) and 0.5 % (P = 0.0391) of inter-individual variability in warfarin dose requirement before and after adjustment for other covariables, respectively. RPA is associated with higher warfarin dose requirement. The relevance of clinical recommendations on RPA to maintain a steady response to warfarin should be assessed in further studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11239-015-1248-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4735233
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-47352332016-02-09 Impact of regular physical activity on weekly warfarin dose requirement Rouleau-Mailloux, Étienne Shahabi, Payman Dumas, Stéphanie Feroz Zada, Yassamin Provost, Sylvie Hu, Jason Nguyen, Jacqueline Bouchama, Nawal Mongrain, Ian Talajic, Mario Tardif, Jean-Claude Perreault, Sylvie Dubé, Marie-Pierre J Thromb Thrombolysis Article Warfarin is an oral anticoagulant agent with a narrow therapeutic index. There is a marked inter- and intra-patient variability in warfarin dose requirement. All factors influencing warfarin response are not known and this study aims to evaluate if regular physical activity (RPA) is a determining factor. RPA level was collected with the Stanford Brief Activity Survey in 1064 incident warfarin users, as part of the Quebec Warfarin Cohort (QWC), and with the Global Physical Activity Questionnaire in 618 patients from the Montreal Heart Institute (MHI) Biobank. Linear regression was performed to model relationship of warfarin dose after 3 months of therapy in the QWC with RPA, while controlling for height, weight, age, CYP2C9 (*2 and *3 alleles) and VKORC1 (*2 allele) genotype. Warfarin dose of prevalent users was modeled in the MHI Biobank for replication. A higher level of physical activity was associated with higher doses of warfarin in both cohorts. In the QWC, physical activity could explain 5.4 % (P < 0.001) and 0.9 % (P = 3.23 × 10(−5)) of variance in dose, in univariate and multivariable models, respectively. Similarly, RPA was found to be associated with 1.7 % (P = 0.0012) and 0.5 % (P = 0.0391) of inter-individual variability in warfarin dose requirement before and after adjustment for other covariables, respectively. RPA is associated with higher warfarin dose requirement. The relevance of clinical recommendations on RPA to maintain a steady response to warfarin should be assessed in further studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11239-015-1248-9) contains supplementary material, which is available to authorized users. Springer US 2015-08-04 2016 /pmc/articles/PMC4735233/ /pubmed/26238769 http://dx.doi.org/10.1007/s11239-015-1248-9 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Rouleau-Mailloux, Étienne
Shahabi, Payman
Dumas, Stéphanie
Feroz Zada, Yassamin
Provost, Sylvie
Hu, Jason
Nguyen, Jacqueline
Bouchama, Nawal
Mongrain, Ian
Talajic, Mario
Tardif, Jean-Claude
Perreault, Sylvie
Dubé, Marie-Pierre
Impact of regular physical activity on weekly warfarin dose requirement
title Impact of regular physical activity on weekly warfarin dose requirement
title_full Impact of regular physical activity on weekly warfarin dose requirement
title_fullStr Impact of regular physical activity on weekly warfarin dose requirement
title_full_unstemmed Impact of regular physical activity on weekly warfarin dose requirement
title_short Impact of regular physical activity on weekly warfarin dose requirement
title_sort impact of regular physical activity on weekly warfarin dose requirement
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735233/
https://www.ncbi.nlm.nih.gov/pubmed/26238769
http://dx.doi.org/10.1007/s11239-015-1248-9
work_keys_str_mv AT rouleaumaillouxetienne impactofregularphysicalactivityonweeklywarfarindoserequirement
AT shahabipayman impactofregularphysicalactivityonweeklywarfarindoserequirement
AT dumasstephanie impactofregularphysicalactivityonweeklywarfarindoserequirement
AT ferozzadayassamin impactofregularphysicalactivityonweeklywarfarindoserequirement
AT provostsylvie impactofregularphysicalactivityonweeklywarfarindoserequirement
AT hujason impactofregularphysicalactivityonweeklywarfarindoserequirement
AT nguyenjacqueline impactofregularphysicalactivityonweeklywarfarindoserequirement
AT bouchamanawal impactofregularphysicalactivityonweeklywarfarindoserequirement
AT mongrainian impactofregularphysicalactivityonweeklywarfarindoserequirement
AT talajicmario impactofregularphysicalactivityonweeklywarfarindoserequirement
AT tardifjeanclaude impactofregularphysicalactivityonweeklywarfarindoserequirement
AT perreaultsylvie impactofregularphysicalactivityonweeklywarfarindoserequirement
AT dubemariepierre impactofregularphysicalactivityonweeklywarfarindoserequirement